Brain Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Cancer, including details on symptoms, benign and malignant tumors, gliomas, treatment.

Volume 6 (2009), Issue 12 (December)

1. YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation.
   Genes Dev, 23(23): 2729-41. [Abstract] [Full-text]
2. Role of stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of recurrent glioblastoma multiforme.
   Neurosurg Focus, 27(6): E8. [Abstract] [Full-text]
3. Stereotactic radiosurgery boost to the resection bed for oligometastatic brain disease: challenging the tradition of adjuvant whole-brain radiotherapy.
   Neurosurg Focus, 27(6): E7. [Abstract] [Full-text]
4. Control of brain metastases using frameless image-guided radiosurgery.
   Neurosurg Focus, 27(6): E6. [Abstract] [Full-text]
5. Longitudinal assessment of regional directed delivery in a rodent malignant glioma model.
   J Neurosurg Pediatr, 4(6): 592-8. [Abstract] [Full-text]
6. Cystic choroid plexus papilloma in the cavum septum pellucidum.
   J Neurosurg Pediatr, 4(6): 580-3. [Abstract] [Full-text]
7. Optimal treatment strategy for intracranial germ cell tumors: a single institution analysis.
   J Neurosurg Pediatr, 4(6): 506-14. [Abstract] [Full-text]
8. Role of diffusion tensor imaging in resection of thalamic juvenile pilocytic astrocytoma.
   J Neurosurg Pediatr, 4(6): 495-505. [Abstract] [Full-text]
9. Noninvasive visualization of retinoblastoma growth and metastasis via bioluminescence imaging.
   Invest Ophthalmol Vis Sci, 50(12): 5544-51. [Abstract] [Full-text]
10. Prognostic significance of growth kinetics in newly diagnosed glioblastomas revealed by combining serial imaging with a novel biomathematical model.
    Cancer Res, 69(23): 9133-40. [Abstract] [Full-text]
11. Glioblastoma proto-oncogene SEC61gamma is required for tumor cell survival and response to endoplasmic reticulum stress.
    Cancer Res, 69(23): 9105-11. [Abstract] [Full-text]
12. Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomas.
    Cancer Res, 69(23): 8932-40. [Abstract] [Full-text]
13. Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology.
    Cancer Res, 69(23): 9065-72. [Abstract] [Full-text]
14. Recognition and killing of brain tumor stem-like initiating cells by CD8+ cytolytic T cells.
    Cancer Res, 69(23): 8886-93. [Abstract] [Full-text]
15. Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors.
    Cancer Cell, 16(6): 533-46. [Abstract] [Full-text]
16. Gli1 is a potential target for alleviating multidrug resistance of gliomas.
    J Neurol Sci, 288(1): 156-66. [Abstract] [Full-text]
17. An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging.
    Neuroimage, 49(2): 1398-405. [Abstract] [Full-text]
18. Cognitive and academic outcome after benign or malignant cerebellar tumor in children.
    Cogn Behav Neurol, 22(4): 270-8. [Abstract] [Full-text]
19. NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.
    J Clin Oncol, 27(35): 5874-80. [Abstract] [Full-text]
20. MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951.
    J Clin Oncol, 27(35): 5881-6. [Abstract] [Full-text]
21. Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study.
    Br J Cancer, 101(12): 1986-94. [Abstract] [Full-text]
22. Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma.
    Br J Cancer, 101(12): 1995-2004. [Abstract] [Full-text]
23. Time trends in brain tumor incidence rates in Denmark, Finland, Norway, and Sweden, 1974-2003.
    J Natl Cancer Inst, 101(24): 1721-4. [Abstract] [Full-text]
24. Mortality from lymphohematopoietic malignancies and brain cancer among embalmers exposed to formaldehyde.
    J Natl Cancer Inst, 101(24): 1696-708. [Abstract] [Full-text]
25. Acyl-CoA synthetase VL3 knockdown inhibits human glioma cell proliferation and tumorigenicity.
    Cancer Res, 69(24): 9175-82. [Abstract] [Full-text]
26. Feasibility of single-isocenter volumetric modulated arc radiosurgery for treatment of multiple brain metastases.
    Int J Radiat Oncol Biol Phys, 76(1): 296-302. [Abstract] [Full-text]
27. Physician expectations of treatment outcomes for patients with brain metastases referred for whole brain radiotherapy.
    Int J Radiat Oncol Biol Phys, 76(1): 187-92. [Abstract] [Full-text]
28. Interactions between antiepileptic and chemotherapeutic drugs in children with brain tumors: is it time to change treatment?
    Pediatr Blood Cancer, 54(2): 193-8. [Abstract] [Full-text]
29. Medical decision-making capacity in patients with malignant glioma.
    Neurology, 73(24): 2086-92. [Abstract] [Full-text]
30. Supratentorial low-grade gliomas in older patients.
    Neurology, 73(24): 2093-8. [Abstract] [Full-text]
31. The potential of resveratrol against human gliomas.
    Anticancer Drugs, 21(2): 140-50. [Abstract] [Full-text]
32. Cerebral blood flow, blood volume, and mean transit time responses to propofol and indomethacin in peritumor and contralateral brain regions: perioperative perfusion-weighted magnetic resonance imaging in patients with brain tumors.
    Anesthesiology, 112(1): 50-6. [Abstract] [Full-text]
33. Cochlear implantation following treatment for medulloblastoma.
    Laryngoscope, 120(1): 139-43. [Abstract] [Full-text]
34. Hyperbaric oxygen therapy for radiation-induced brain necrosis in a patient with primary central nervous system lymphoma.
    J Surg Oncol, 100(8): 732-5. [Abstract] [Full-text]
35. Isolation of targeting nanobodies against co-opted tumor vasculature.
    Lab Invest, 90(1): 61-7. [Abstract] [Full-text]
36. Controversies concerning the application of brachytherapy in central nervous system tumors.
    J Cancer Res Clin Oncol, 136(2): 173-85. [Abstract] [Full-text]

© 2004-2012 Brain Cancer Research Today. All Rights Reserved.